GOMEKLI™ is an oral, small molecule MEK inhibitor approved in the United States for the treatment of adult and pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have ...

【导读】子宫内膜癌（EC）是威胁妇女健康的重大疾病，治疗后的复发是一大挑战。虽然胆固醇代谢异常被认为与子宫内膜癌的进展有关，但其潜在机制仍不清楚。在这项研究中，团队发现羊毛甾醇合成酶（LSS）是与乳腺癌相关的胆固醇代谢的关键介质。2025年2月8日， ...

NEW YORK – Immuneering on Thursday said it signed a clinical supply agreement with Regeneron to obtain the anti-PD-1 therapy Libtayo (cemiplimab) for a Phase IIa trial testing Immuneering's MEK ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Olive oil bioactives, including MUFAs, polyphenols, and triterpenoids, modulate gene expression linked to insulin sensitivity ...

MIAMI - Pasithea Therapeutics Corp. (NASDAQ: KTTA), a micro-cap biotech firm with a market capitalization of $2.63 million focusing on developing treatments for central nervous system disorders and ...

Pasithea Therapeutics (KTTA) announced that the external Safety Review Committee recommended that the Company’s Phase 1 clinical trial of ...

Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for cancer patients, ...

SAN DIEGO, Jan. 31, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with ...

In cancer-associated cachexia, elevated TNF-α and IL-6 exacerbate muscle and fat loss by regulating multiple metabolic signaling pathways, which could be ameliorated by Z526's suppression of NF-κB ...

Deciso is thrilled to announce the release of OPNsense® 25.1, aptly named 'Ultimate Unicorn', marking a decade of unwavering commitment to open-source security excellence. This milestone release ...

FORTUNE® magazine has recognized Broadridge Financial Solutions, Inc. as one of the 2025 World's Most Admired Companies. This marks the company's 11th time being named to the prestigious list within ...